Bausch Health Companies (BHC) Curent Deferred Tax Liability (2010 - 2015)
Bausch Health Companies' (BHC) quarterly Curent Deferred Tax Liability came in at $11.6 million in Q3 2015, down 38.95% year-on-year from $19.0 million in Q3 2014, and down 69.63% quarter-over-quarter from $38.2 million in Q2 2015.
Bausch Health Companies (BHC) Curent Deferred Tax Liability (2010 - 2015) Analysis & Trends
Bausch Health Companies has disclosed Curent Deferred Tax Liability across 6 years of filings, most recently posting $11.6 million for Q3 2015.
- Curent Deferred Tax Liability for Q3 2015 came in at $11.6 million, down 38.95% year-over-year; the trailing twelve-month figure through Sep 2015 was $11.6 million (down 38.95% YoY), and the FY2014 annual result was $10.7 million, down 83.79% from the prior year.
- Curent Deferred Tax Liability came in at $11.6 million for Q3 2015 at Bausch Health Companies, down from $38.2 million in the prior quarter.
- In the past five years, Curent Deferred Tax Liability ranged from a high of $66.0 million in Q4 2013 to a low of $1.9 million in Q1 2011.
- The 5-year median for Curent Deferred Tax Liability is $8.2 million (2012), against an average of $15.5 million.
- Across the five-year window, Curent Deferred Tax Liability soared 1398.98% in 2013 and slumped 83.79% in 2014, its largest moves.
- Bausch Health Companies' Curent Deferred Tax Liability stood at $4.4 million in 2011, then slipped by 0.79% to $4.4 million in 2012, then jumped by 1398.98% to $66.0 million in 2013, then plunged by 83.79% to $10.7 million in 2014, then climbed by 8.41% to $11.6 million in 2015.
- The last three Curent Deferred Tax Liability figures came in at $11.6 million (Q3 2015), $38.2 million (Q2 2015), and $10.7 million (Q4 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 11.60 Mn |
| Sep 30, 2015 | 11.60 Mn |
| Jun 30, 2015 | 38.20 Mn |
| Jun 30, 2015 | 38.20 Mn |
| Dec 31, 2014 | 10.70 Mn |
| Dec 31, 2014 | 10.70 Mn |
| Sep 30, 2014 | 19.00 Mn |
| Sep 30, 2014 | 19.00 Mn |
| Jun 30, 2014 | 11.00 Mn |
| Jun 30, 2014 | 11.00 Mn |
| Mar 31, 2014 | 10.80 Mn |
| Mar 31, 2014 | 10.80 Mn |
| Dec 31, 2013 | 66.00 Mn |
| Dec 31, 2013 | 66.00 Mn |
| Sep 30, 2013 | 64.19 Mn |
| Sep 30, 2013 | 64.19 Mn |
| Jun 30, 2013 | 4.36 Mn |
| Jun 30, 2013 | 4.36 Mn |
| Mar 31, 2013 | 4.29 Mn |
| Mar 31, 2013 | 4.29 Mn |